FBXO45 and ovarian carcinoma: It has been reported that FBXO45 regulates malignant behaviors such as cell proliferation, metastasis, and drug resistance by ubiquitinating and degrading FBXW7 (46), and ZEB1 (47), but its function in ovarian cancer has not been reported.